SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-010572
Filing Date
2023-05-30
Accepted
2023-05-30 08:45:35
Documents
12
Period of Report
2023-05-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mrns-20230524x8k.htm   iXBRL 8-K 59881
  Complete submission text file 0001558370-23-010572.txt   184242

Data Files

Seq Description Document Type Size
2 EX-101.SCH mrns-20230524.xsd EX-101.SCH 3119
3 EX-101.LAB mrns-20230524_lab.xml EX-101.LAB 16592
4 EX-101.PRE mrns-20230524_pre.xml EX-101.PRE 10714
6 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20230524x8k_htm.xml XML 5063
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 23971616
SIC: 2834 Pharmaceutical Preparations